{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:32:05Z","timestamp":1792809125191,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T00:00:00Z","timestamp":1640736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Physiology"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.crphys.2021.12.004","type":"journal-article","created":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T13:07:33Z","timestamp":1641042453000},"page":"36-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["A New Prospect for the Treatment of Nephrotic Syndrome Based on Network Pharmacology Analysis"],"prefix":"10.1016","volume":"5","author":[{"given":"Rini","family":"Varghese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.crphys.2021.12.004_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/ckj\/sfv109","article-title":"Chronic kidney disease hotspots in developing countries in South Asia","volume":"9","author":"Abraham","year":"2016","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.crphys.2021.12.004_bib2","volume":"vol. 1","author":"Avner","year":"2009"},{"key":"10.1016\/j.crphys.2021.12.004_bib3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/nar\/gki070","article-title":"The Universal Protein Resource (UniProt)","volume":"33","author":"Bairoch","year":"2005","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.crphys.2021.12.004_bib4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00439-013-1271-x","article-title":"Genetic syndromes caused by mutations in epigenetic genes","volume":"132","author":"Berdasco","year":"2013","journal-title":"Hum. Genet."},{"issue":"12","key":"10.1016\/j.crphys.2021.12.004_bib5","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1093\/ndt\/gfm393","article-title":"Treatment targets in renal fibrosis","volume":"22","author":"Boor","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"issue":"12","key":"10.1016\/j.crphys.2021.12.004_bib6","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/cncr.21589","article-title":"Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia","volume":"104","author":"Bug","year":"2005","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.crphys.2021.12.004_bib7","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00421.2006","article-title":"Role of matrix metalloproteinases in renal pathophysiologies","volume":"292","author":"Catania","year":"2007","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"3","key":"10.1016\/j.crphys.2021.12.004_bib8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.16943\/ptinsa\/2015\/v81i3\/48229","article-title":"Network pharmacology: an emerging technique for natural product drug discovery and scientific research on ayurveda","volume":"81","author":"Chandran","year":"2015","journal-title":"Proc. Indian Natl. Sci. Acad."},{"issue":"9","key":"10.1016\/j.crphys.2021.12.004_bib9","doi-asserted-by":"crossref","first-page":"846","DOI":"10.2174\/1386207318666151019093606","article-title":"Network pharmacology of ayurveda formulation triphala with special reference to anti-cancer property","volume":"18","author":"Chandran","year":"2015","journal-title":"Comb. Chem. High Throughput Screen."},{"issue":"17","key":"10.1016\/j.crphys.2021.12.004_bib10","doi-asserted-by":"crossref","first-page":"8903","DOI":"10.1158\/0008-5472.CAN-05-2726","article-title":"Sequential valproic acid\/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia","volume":"66","author":"Cimino","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.crphys.2021.12.004_bib11","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/00001813-199711000-00007","article-title":"Sodium Valproate Inhibits in vivo growth of Human neuroblastoma cells","volume":"8","author":"Cinatl","year":"1997","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.crphys.2021.12.004_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2016.06.023","article-title":"PPAR\u03b3 as a therapeutic target to rescue mitochondrial function in neurological disease","volume":"100","author":"Corona","year":"2016","journal-title":"Free Radic. Biol. Med."},{"issue":"10","key":"10.1016\/j.crphys.2021.12.004_bib13","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s40261-018-0683-8","article-title":"A network pharmacology-based analysis of multi-target, multi-pathway, multi-compound treatment for ovarian serous cystadenocarcinoma","volume":"38","author":"dan Xiong","year":"2018","journal-title":"Clin. Drug Invest."},{"issue":"3","key":"10.1016\/j.crphys.2021.12.004_bib14","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/bioinformatics\/btf851","article-title":"Genetic network analyzer: qualitative simulation of genetic regulatory networks","volume":"19","author":"de Jong","year":"2003","journal-title":"Bioinformatics"},{"issue":"26","key":"10.1016\/j.crphys.2021.12.004_bib15","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"369","author":"de Zeeuw","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.crphys.2021.12.004_bib16","series-title":"Database tool DisGeNET : a Discovery Platform for the Dynamical Exploration of Human Diseases and their Genes","first-page":"1","author":"Deu-pons","year":"2015"},{"key":"10.1016\/j.crphys.2021.12.004_bib17","first-page":"1","article-title":"A network pharmacology approach to uncover the mechanisms of Shen-Qi-Di-Huang decoction against diabetic nephropathy","volume":"2018","author":"Di","year":"2018","journal-title":"Evid. base Compl. Alternative Med."},{"issue":"1","key":"10.1016\/j.crphys.2021.12.004_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-98925-6","article-title":"Network pharmacology-based investigation of potential targets of astragalus membranaceous-angelica sinensis compound acting on diabetic nephropathy","volume":"11","author":"Dong","year":"2021","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.crphys.2021.12.004_bib19","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s00467-007-0521-3","article-title":"Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications","volume":"22","author":"Doucet","year":"2007","journal-title":"Pediatr. Nephrol."},{"issue":"3","key":"10.1016\/j.crphys.2021.12.004_bib20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ctrv.2007.11.003","article-title":"Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors","volume":"34","author":"Duenas-Gonzalez","year":"2008","journal-title":"Cancer Treat Rev."},{"issue":"5","key":"10.1016\/j.crphys.2021.12.004_bib21","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1172\/JCI17423","article-title":"Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases","volume":"111","author":"Eremina","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.crphys.2021.12.004_bib22","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2174\/156652412799218949","article-title":"Combination of valproic acid and ATRA restores RAR\u03b22 expression and induces differentiation in cervical cancer through the PI3K\/Akt pathway","volume":"12","author":"Feng","year":"2012","journal-title":"Curr. Mol. Med."},{"issue":"1","key":"10.1016\/j.crphys.2021.12.004_bib23","first-page":"1","article-title":"Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation","volume":"8","author":"Gao","year":"2018","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.crphys.2021.12.004_bib24","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1172\/JCI79504","article-title":"KANK deficiency leads to podocyte dysfunction and nephrotic syndrome","volume":"125","author":"Gee","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.crphys.2021.12.004_bib25","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nrneph.2016.163","article-title":"The global burden of chronic kidney disease: estimates, variability and pitfalls","volume":"13","author":"Glassock","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"issue":"9","key":"10.1016\/j.crphys.2021.12.004_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092630","article-title":"Histone deacetylase inhibitors and diabetic kidney disease","volume":"19","author":"Hadden","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.crphys.2021.12.004_bib27","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1681\/ASN.2017121338","article-title":"The human FSGS-causing ANLN R431C mutation induces dysregulated PI3K\/AKT\/mTOR\/Rac1 signaling in podocytes","volume":"29","author":"Hall","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.crphys.2021.12.004_bib28","first-page":"1155","article-title":"Organelle stress and crosstalk in kidney disease","volume":"1","author":"Hasegawa","year":"2020","journal-title":"Kidney"},{"issue":"11","key":"10.1016\/j.crphys.2021.12.004_bib29","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat. Chem. Biol."},{"issue":"21","key":"10.1016\/j.crphys.2021.12.004_bib30","doi-asserted-by":"crossref","first-page":"8685","DOI":"10.1073\/pnas.0701361104","article-title":"The human disease network","volume":"104","author":"Il Goh","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.crphys.2021.12.004_bib31","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1172\/JCI124030","article-title":"Podocyte histone deacetylase activity regulates murine and human glomerular diseases","volume":"129","author":"Inoue","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.crphys.2021.12.004_bib32","first-page":"1295","article-title":"Podocyte histone deacetylase activity regulates murine and human glomerular diseases Podocyte histone deacetylase activity regulates murine and human glomerular diseases","volume":"129","author":"Inoue","year":"2019"},{"issue":"3","key":"10.1016\/j.crphys.2021.12.004_bib33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1172\/JCI0215518","article-title":"Evidence that fibroblasts derive from epithelium during tissue fibrosis","volume":"110","author":"Iwano","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"Suppl. 1","key":"10.1016\/j.crphys.2021.12.004_bib34","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/nar\/gkn760","article-title":"STRING 8-A global view on proteins and their functional interactions in 630 organisms","volume":"37","author":"Jensen","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.crphys.2021.12.004_bib35","first-page":"91","volume":"vol. 247","author":"Kanehisa","year":"2002"},{"key":"10.1016\/j.crphys.2021.12.004_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biochi.2014.12.015","article-title":"Valproate attenuates the proteinuria, podocyte and renal injury by facilitating autophagy and inactivation of NF-\u03baB\/iNOS signaling in diabetic rat","volume":"110","author":"Khan","year":"2015","journal-title":"Biochimie"},{"issue":"6","key":"10.1016\/j.crphys.2021.12.004_bib37","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.3349\/ymj.2015.56.6.1597","article-title":"All-trans retinoic acid has a potential therapeutic role for diabetic nephropathy","volume":"56","author":"Kim","year":"2015","journal-title":"Yonsei Med. J."},{"issue":"11","key":"10.1016\/j.crphys.2021.12.004_bib38","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1681\/ASN.2012040389","article-title":"Treatment of primary FSGS in adults","volume":"23","author":"Korbet","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"issue":"13","key":"10.1016\/j.crphys.2021.12.004_bib39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00277-005-0026-8","article-title":"Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia","volume":"84","author":"Kuendgen","year":"2005","journal-title":"Ann. Hematol. Suppl."},{"issue":"2","key":"10.1016\/j.crphys.2021.12.004_bib40","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3724\/SP.J.1009.2013.00110","article-title":"Traditional Chinese medicine network pharmacology: theory, methodology and application","volume":"11","author":"Li","year":"2014","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.crphys.2021.12.004_bib41","first-page":"1","article-title":"Based on network pharmacology tools to investigate the molecular mechanism of Cordyceps sinensis on the treatment of diabetic nephropathy","volume":"2021","author":"Li","year":"2021","journal-title":"J. Diabetes Res."},{"issue":"2","key":"10.1016\/j.crphys.2021.12.004_bib42","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1681\/ASN.2008121226","article-title":"New insights into epithelial-mesenchymal transition in kidney fibrosis","volume":"21","author":"Liu","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"issue":"Suppl. 1","key":"10.1016\/j.crphys.2021.12.004_bib43","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/nar\/gkl999","article-title":"BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities","volume":"35","author":"Liu","year":"2007","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.crphys.2021.12.004_bib44","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1745-7254.2008.00849.x","article-title":"All-trans retinoic acid inhibits the increases in fibronectin and PAI-1 induced by TGF-\u03b21 and Ang II in rat mesangial cells","volume":"29","author":"Liu","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.crphys.2021.12.004_bib45","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/aps.2010.200","article-title":"Amelioration of glomerulosclerosis with all-trans retinoic acid is linked to decreased plasminogen activator inhibitor-1 and \u03b1-smooth muscle actin","volume":"32","author":"Liu","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.crphys.2021.12.004_bib46","series-title":"Histone Deacetylases Take Center Stage on Regulation of Podocyte Function","first-page":"236","author":"Liu","year":"2020"},{"key":"10.1016\/j.crphys.2021.12.004_bib47","first-page":"1","article-title":"Silencing of histone deacetylase 9 expression in podocytes attenuates kidney injury in diabetic nephropathy","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.crphys.2021.12.004_bib48","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1039\/c4mb00105b","article-title":"Systems pharmacology strategies for anticancer drug discovery based on natural products","volume":"10","author":"Luo","year":"2014","journal-title":"Mol. Biosyst."},{"issue":"7","key":"10.1016\/j.crphys.2021.12.004_bib49","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"issue":"3 SPEC. ISS","key":"10.1016\/j.crphys.2021.12.004_bib50","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00467-004-1623-9","article-title":"Impact of inflammation and oxidative stress on vascular calcifications in chronic kidney disease","volume":"20","author":"Massy","year":"2005","journal-title":"Pediatr. Nephrol."},{"issue":"8","key":"10.1016\/j.crphys.2021.12.004_bib51","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s00467-009-1138-5","article-title":"Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study","volume":"24","author":"Mekahli","year":"2009","journal-title":"Pediatr. Nephrol."},{"issue":"4","key":"10.1016\/j.crphys.2021.12.004_bib52","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1046\/j.1523-1755.2001.00941.x","article-title":"Tubular NF-\u03baB and AP-1 activation in human proteinuric renal disease","volume":"60","author":"Mezzano","year":"2001","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.crphys.2021.12.004_bib53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2169\/internalmedicine.43.9","article-title":"Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure","volume":"43","author":"Nangaku","year":"2004","journal-title":"Intern. Med."},{"issue":"15","key":"10.1016\/j.crphys.2021.12.004_bib54","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/pmic.201400515","article-title":"FunRich: an open access standalone functional enrichment and interaction network analysis tool","volume":"15","author":"Pathan","year":"2015","journal-title":"Proteomics"},{"key":"10.1016\/j.crphys.2021.12.004_bib55","first-page":"1","article-title":"Mechanism of Cordyceps Cicadae in treating diabetic nephropathy based on network pharmacology and molecular docking analysis","volume":"2021","author":"Qian","year":"2021","journal-title":"J. Diabetes Res."},{"issue":"7","key":"10.1016\/j.crphys.2021.12.004_bib56","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/aps.2016.53","article-title":"Identification of the anti-tumor activity and mechanisms of nuciferine through a network pharmacology approach","volume":"37","author":"Qi","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"issue":"9677","key":"10.1016\/j.crphys.2021.12.004_bib57","doi-asserted-by":"crossref","first-page":"172551","DOI":"10.1016\/j.ejphar.2019.172551","article-title":"Up-regulation of TIF1\u03b3 by valproic acid inhibits the epithelial mesenchymal transition in prostate carcinoma through TGF-\u03b2\/Smad signaling pathway","volume":"860","author":"Qi","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.crphys.2021.12.004_bib58","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11693-013-9123-5","article-title":"The organisational structure of protein networks: revisiting the centrality-lethality hypothesis","volume":"8","author":"Raman","year":"2014","journal-title":"Syst. Synth. Biol."},{"issue":"3","key":"10.1016\/j.crphys.2021.12.004_bib59","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3109\/10799893.2015.1101137","article-title":"CD2-associated protein participates in podocyte apoptosis via PI3K\/Akt signaling pathway","volume":"36","author":"Ren","year":"2016","journal-title":"J. Recept. Signal Transduct."},{"key":"10.1016\/j.crphys.2021.12.004_bib60","doi-asserted-by":"crossref","first-page":"104000","DOI":"10.1016\/j.micpath.2020.104000","article-title":"nteractome networks between the human respiratory syncytial virus (HRSV), the human metapneumovirus (\u0397MPV), and their host: in silico investigation and comparative functional enrichment analysis","volume":"141","author":"Rouka","year":"2020","journal-title":"Microb. Pathog."},{"issue":"6","key":"10.1016\/j.crphys.2021.12.004_bib61","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/ki.2012.439","article-title":"Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease","volume":"83","author":"Ruiz","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.crphys.2021.12.004_bib62","first-page":"1","article-title":"Recent advances in understanding and treating nephrotic syndrome","volume":"6","author":"Saleem","year":"2017","journal-title":"F1000Research"},{"issue":"3","key":"10.1016\/j.crphys.2021.12.004_bib63","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tibs.2015.01.002","article-title":"UPR, autophagy, and mitochondria crosstalk underlies the ER stress response","volume":"40","author":"Senft","year":"2015","journal-title":"Trends Biochem. Sci."},{"issue":"11","key":"10.1016\/j.crphys.2021.12.004_bib64","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software Environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.crphys.2021.12.004_bib65","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jnutbio.2018.06.002","article-title":"All-trans retinoic acid ameliorates inflammatory response mediated by TLR4\/NF-\u03baB during initiation of diabetic nephropathy","volume":"60","author":"Sierra-Mondragon","year":"2018","journal-title":"J. Nutr. Biochem."},{"issue":"10","key":"10.1016\/j.crphys.2021.12.004_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/biom9100525","article-title":"All-trans retinoic acid attenuates fibrotic processes by downregulating tgf-\u03b21\/smad3 in early diabetic nephropathy","volume":"9","author":"Sierra-Mondragon","year":"2019","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.crphys.2021.12.004_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2369-14-114","article-title":"Epidemiology and risk factors of chronic kidney disease in India - results from the SEEK (screening and early evaluation of kidney disease) study","volume":"14","author":"Singh","year":"2013","journal-title":"BMC Nephrol."},{"issue":"1","key":"10.1016\/j.crphys.2021.12.004_bib68","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1582-4934.2005.tb00337.x","article-title":"The activation of Akt\/PKB signaling pathway and cell survival","volume":"9","author":"Song","year":"2005","journal-title":"J. Cell Mol. Med."},{"issue":"7","key":"10.1016\/j.crphys.2021.12.004_bib69","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1182\/blood-2007-03-078576","article-title":"Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome","volume":"110","author":"Soriano","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.crphys.2021.12.004_bib70","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2353\/ajpath.2010.090767","article-title":"Deletion of von Hippel-Lindau in glomerular podocytes results in glomerular basement membrane thickening, ectopic subepithelial deposition of collagen \u03b11\u03b12\u03b11(IV), expression of neuroglobin, and proteinuria","volume":"177","author":"Steenhard","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.crphys.2021.12.004_bib71","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1681\/ASN.2010111196","article-title":"Valproic acid attenuates proteinuria and kidney injury","volume":"22","author":"Van Beneden","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.crphys.2021.12.004_bib72","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.taap.2013.05.013","article-title":"Comparison of trichostatin A and valproic acid treatment regimens in a mouse model of kidney fibrosis","volume":"271","author":"Van Beneden","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.crphys.2021.12.004_bib73","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.crbiot.2021.05.007","article-title":"Current research in biotechnology current therapies in nephrotic syndrome : HDAC inhibitors, an emerging therapy for kidney diseases","volume":"3","author":"Varghese","year":"2021","journal-title":"Curr. Res. Biotechnol."},{"issue":"4","key":"10.1016\/j.crphys.2021.12.004_bib74","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/ki.2014.111","article-title":"Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy","volume":"86","author":"Wang","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.crphys.2021.12.004_bib75","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2147\/COPD.S121079","article-title":"Network pharmacology-based identification of key pharmacological pathways of yin\u2013huang\u2013qing\u2013fei capsule acting on chronic bronchitis","volume":"12","author":"Yu","year":"2016","journal-title":"Int. J. COPD"},{"key":"10.1016\/j.crphys.2021.12.004_bib76","first-page":"1","article-title":"Identify the key active ingredients and pharmacological mechanisms of compound XiongShao capsule in treating diabetic peripheral neuropathy by network pharmacology approach","volume":"2019","author":"Yu","year":"2019","journal-title":"Evid. base Compl. Alternative Med."},{"key":"10.1016\/j.crphys.2021.12.004_bib77","series-title":"Integrated Network Pharmacology Analysis and Pharmacological Evaluation to Explore the Active Components and Mechanism of Abelmoschus Manihot (L.) Medik. on Renal Fibrosis","author":"Zhang","year":"2020"},{"key":"10.1016\/j.crphys.2021.12.004_bib78","first-page":"1","article-title":"Network pharmacology: a new approach for Chinese herbal medicine research","volume":"2013","author":"Zhang","year":"2013","journal-title":"Evid. base Compl. Alternative Med."},{"issue":"1","key":"10.1016\/j.crphys.2021.12.004_bib79","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/0886022X.2018.1456459","article-title":"Atra attenuate proteinuria via downregulation of TRPC6 in glomerulosclerosis rats induced by adriamycin","volume":"40","author":"Zhang","year":"2018","journal-title":"Ren. Fail."},{"issue":"17","key":"10.1016\/j.crphys.2021.12.004_bib80","article-title":"Chronic kidney disease","volume":"97","author":"Zhou","year":"2008"},{"issue":"1\u20132","key":"10.1016\/j.crphys.2021.12.004_bib81","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drudis.2006.11.008","article-title":"Multi-target therapeutics: when the whole is greater than the sum of the parts","volume":"12","author":"Zimmermann","year":"2007","journal-title":"Drug Discov. Today"}],"container-title":["Current Research in Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2665944121000353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2665944121000353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T09:41:15Z","timestamp":1762940475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2665944121000353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":81,"alternative-id":["S2665944121000353"],"URL":"https:\/\/doi.org\/10.1016\/j.crphys.2021.12.004","relation":{},"ISSN":["2665-9441"],"issn-type":[{"value":"2665-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A New Prospect for the Treatment of Nephrotic Syndrome Based on Network Pharmacology Analysis","name":"articletitle","label":"Article Title"},{"value":"Current Research in Physiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crphys.2021.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}